Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 435

1.

Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ.

Chan KC, Knox WF, Sinha G, Gandhi A, Barr L, Baildam AD, Bundred NJ.

Cancer. 2001 Jan 1;91(1):9-16.

PMID:
11148554
2.

Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.

Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R.

Breast J. 2005 Jul-Aug;11(4):242-7.

PMID:
15982389
3.

Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5.

PMID:
12459354
4.

Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.

Monteau A, Sigal-Zafrani B, Kirova YM, Fourchotte V, Bollet MA, Vincent-Salomon A, Asselain B, Salmon RJ, Fourquet A.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1021-8. doi: 10.1016/j.ijrobp.2008.12.014. Epub 2009 Apr 20.

PMID:
19386441
5.

Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.

Am J Surg. 2006 Oct;192(4):427-33.

PMID:
16978943
6.

Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Chuwa EW, Tan VH, Tan PH, Yong WS, Ho GH, Wong CY.

ANZ J Surg. 2008 Jan-Feb;78(1-2):42-8. doi: 10.1111/j.1445-2197.2007.04354.x.

PMID:
18199204
7.

Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.

Macdonald HR, Silverstein MJ, Lee LA, Ye W, Sanghavi P, Holmes DR, Silberman H, Lagios M.

Am J Surg. 2006 Oct;192(4):420-2.

PMID:
16978941
9.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. Epub 2005 Jul 11.

PMID:
16005576
10.

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

Neuschatz AC, DiPetrillo T, Steinhoff M, Safaii H, Yunes M, Landa M, Chung M, Cady B, Wazer DE.

Cancer. 2002 Apr 1;94(7):1917-24.

11.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.

J Clin Oncol. 2006 Jul 20;24(21):3381-7. Epub 2006 Jun 26.

PMID:
16801628
12.

Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.

Goldstein NS, Vicini FA, Kestin LL, Thomas M.

Cancer. 2000 Jun 1;88(11):2553-60.

PMID:
10861433
13.

Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.

Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.

Cancer. 2004 Aug 1;101(3):508-17.

14.

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.

Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ.

Br J Surg. 2003 Apr;90(4):426-32.

PMID:
12673743
15.

Factors affecting successful breast conservation for ductal carcinoma in situ.

Dillon MF, Mc Dermott EW, O'Doherty A, Quinn CM, Hill AD, O'Higgins N.

Ann Surg Oncol. 2007 May;14(5):1618-28. Epub 2007 Feb 14.

PMID:
17443388
16.

Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.

Olson TP, Harter J, Muñoz A, Mahvi DM, Breslin T.

Ann Surg Oncol. 2007 Oct;14(10):2953-60. Epub 2007 Aug 3.

PMID:
17674109
17.

Predictors of surgical margin status in breast-conserving surgery within a breast screening program.

Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB.

Ann Surg Oncol. 2008 Sep;15(9):2542-9. doi: 10.1245/s10434-008-0054-4. Epub 2008 Jul 10.

PMID:
18618180
18.

Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.

Jenkinson AD, Al-Mufti RA, Mohsen Y, Berry MJ, Wells C, Carpenter R.

Eur J Surg Oncol. 2001 Feb;27(1):21-5.

PMID:
11237487
19.

Predictors of local recurrence following excision alone for ductal carcinoma in situ.

Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ.

Cancer. 1999 Jan 15;85(2):427-31.

PMID:
10023711
20.

Supplemental Content

Support Center